TABLE 2.

Biological results for 3 cystic fibrosis patients with Aspergillus rhinosinusitis and bronchitis^g

Patient no.	Age (yr)	Gendera	Aspergillosis diagnosis	Serum sample no.	Antibodies to A. fumigatus				Total IgEe (kIU/liter)	No. of Aspergillus colonies in sputum
					rAspf4c (kAU/liter)	rAspf6c (kAU/liter)	IgGb index	IE (precipitin no., enzymatic activitiesd)
18	6	M	Bronchitis	74	<0.10	<0.10	2.19	5, cat+	48	ND
				75	<0.10	<0.10	1.78	6, cat+	44	3
				76	<0.10	<0.10	0.38	0	26	ND
				77	<0.10	<0.10	2.33	4, cat+	94	2
				78	<0.10	<0.10	2.2	6	NDf	1
19	23	F	Bronchitis	79	0.55	1.33	0.25	1	96	12
				80	0.86	2.33	2.58	3	200	5
				81	0.35	1.03	3.41	3	124	12
				82	0.32	1.06	2.29	4, cat+	115	8
				83	0.19	0.87	0.99	10, cat+	101	41
20	18	F	Colonization	84	<0.10	<0.10	0.91	6	162	8
				85	<0.10	<0.10	0.86	7, cat+	298	5
			Sinusitis	86	<0.10	<0.10	1.36	7, cat+, chym+	ND	40
				87	<0.10	<0.10	3.24	5, cat+	ND	20
				88	<0.10	<0.10	1.35	5	ND	3

^aM, male; F, female.

^bAnti-Aspergillus ELISA IgG. An index value of >0.75 was considered positive.

^cSpecific IgE against two A. fumigatus recombinants measured by the Pharmacia UniCAP method. A result of >0.1 kAU/liter was considered positive.

^dIE for precipitin detection. More than 2 precipitin lines was considered positive. Positive enzymatic activities (catalase and chymotrypsin) are indicated (+).

^eTotal IgE measured by the Pharmacia UniCAP method. A result of >500 kIU/liter was considered positive.

^fND, not determined.

^gPositive results are shown in boldface type.